Comparison of two exercise- therapy programs on indices of muscular strength in female type 2 diabetes mellitus patients.

Comparison of two exercise- therapy programs on indices of muscular strength in female type 2 diabetes mellitus patients: a double blind randomized controlled trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201104256283N1

Enrollment

Registered

2011-12-27

Start date

2011-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise therapy programs in Non-insulin-dependent diabetes mellitus type II. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Supervised exercise protocol (SEP). Intervention 2: Home-based exercise protocol (HEP).

Supervised exercise protocol (SEP)

Home-based exercise protocol (HEP)

Eligibility

Sex/Gender

Female

Age

30 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Type 2 diabetes mellitus; Age range: 30-55 years; Female; Treated by Oral Anti Diabetic agents; HbA1C=8-10%. Exclusion criteria: High blood pressure; Insulin therapy; B-Blocker agents; Ca- Channel blockers; Nitrates; Cardio Vascular Diseases; Micro vascular and Macro vascular side effects of Diabetes Mellitus; History of moderate to sever muscoloskeletal disorders;Anemia (Hb lower than12); Pregnancy;Tobacco smoking; Alcohol abuse.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Strenght changes of concentric and eccentric muscles. Timepoint: 72-96 hours before the initiation of the protocols , 72-96 hours after the conclusion of the protocols. Method of measurement: Isokinetic test by Kin Kam device.	—

Secondary

Measure	Time frame
Eccentric average torque of non-dominant knee extensors. Timepoint: 72-96 hours before the initiation of the protocols , 72-96 hours after the conclusion of the protocols. Method of measurement: Isokinetic test.;Maximal concentric angular velocity of non-dominant knee extensors. Timepoint: 72-96 hours before the initiation of the protocols , 72-96 hours after the conclusion of the protocols. Method of measurement: Isokinetic test.;Eccentric peak torque of non-dominant knee extensors. Timepoint: 72-96 hours before the initiation of the protocols , 72-96 hours after the conclusion of the protocols. Method of measurement: Isokinetic test.;Concentric avereage torque of non-dominant knee extensors. Timepoint: 72-96 hours before the initiation of the protocols , 72-96 hours after the conclusion of the protocols. Method of measurement: Isokinetic test.;Maximal eccentric angular velocity of non-dominant knee extensors. Timepoint: 72-96 hours before the initiation of the protocols , 72-96 hours after the conclusion of the protocols. Method of measurement: Isokinetic test.	—

Measure

Time frame

Eccentric average torque of non-dominant knee extensors. Timepoint: 72-96 hours before the initiation of the protocols , 72-96 hours after the conclusion of the protocols. Method of measurement: Isokinetic test.;Maximal concentric angular velocity of non-dominant knee extensors. Timepoint: 72-96 hours before the initiation of the protocols , 72-96 hours after the conclusion of the protocols. Method of measurement: Isokinetic test.;Eccentric peak torque of non-dominant knee extensors. Timepoint: 72-96 hours before the initiation of the protocols , 72-96 hours after the conclusion of the protocols. Method of measurement: Isokinetic test.;Concentric avereage torque of non-dominant knee extensors. Timepoint: 72-96 hours before the initiation of the protocols , 72-96 hours after the conclusion of the protocols. Method of measurement: Isokinetic test.;Maximal eccentric angular velocity of non-dominant knee extensors. Timepoint: 72-96 hours before the initiation of the protocols , 72-96 hours after the conclusion of the protocols. Method of measurement: Isokinetic test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Laily Najafi

Endocrine research center (Firozgar), Tehran University of Medical Sciences

l.najafi@yahoo.com+98 21 8894 5247

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026